Eagle Pharmaceuticals Inc (EGRX)
0.95
+0.05
(+5.56%)
USD |
OTCM |
Nov 22, 16:00
Eagle Pharmaceuticals Cash from Financing (Quarterly): -6.411M for June 30, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | -6.411M |
March 31, 2023 | 12.65M |
December 31, 2022 | 2.389M |
September 30, 2022 | 3.296M |
June 30, 2022 | -0.536M |
March 31, 2022 | -11.36M |
December 31, 2021 | -10.11M |
September 30, 2021 | -10.04M |
June 30, 2021 | -5.22M |
March 31, 2021 | -3.02M |
December 31, 2020 | -6.116M |
September 30, 2020 | -23.96M |
June 30, 2020 | -114.85M |
March 31, 2020 | 107.06M |
December 31, 2019 | -4.105M |
September 30, 2019 | -1.227M |
June 30, 2019 | -16.24M |
March 31, 2019 | -2.656M |
December 31, 2018 | -50.46M |
September 30, 2018 | -12.68M |
June 30, 2018 | -1.09M |
March 31, 2018 | -23.89M |
Date | Value |
---|---|
December 31, 2017 | -6.079M |
September 30, 2017 | 35.85M |
June 30, 2017 | -9.665M |
March 31, 2017 | -12.00M |
December 31, 2016 | -18.43M |
September 30, 2016 | -15.24M |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.386M |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.167M |
March 31, 2015 | 55.26M |
December 31, 2014 | 0.034M |
September 30, 2014 | 0.0651M |
June 30, 2014 | -0.4182M |
March 31, 2014 | 47.01M |
December 31, 2013 | -0.498M |
September 30, 2013 | -0.0197M |
June 30, 2013 | 9.911M |
March 31, 2013 | -0.0825M |
December 31, 2012 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-114.85M
Minimum
Jun 2020
107.06M
Maximum
Mar 2020
-4.689M
Average
-5.22M
Median
Jun 2021
Cash from Financing (Quarterly) Benchmarks
Eli Lilly and Co | 211.30M |
Verrica Pharmaceuticals Inc | -0.397M |
NovaBay Pharmaceuticals Inc | 2.089M |
Palatin Technologies Inc | -0.127M |
iBio Inc | -0.162M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -0.126M |
Cash from Investing (Quarterly) | -0.006M |